CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943134940
- Phone
- 4154825300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $43,476
- in 2 filings
Net −$43,476. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-17 | Labrucherie Gil M SVP, COO & CFO | Sale | −7,898 | $18.30 | $145K | 251,098 |
| 2021-05-12 | CHESS ROBERT Director | Option exercise | +8,000 | $13.80 | $110K | 288,573 |
| 2021-05-12 | CHESS ROBERT Director | Sale | −8,000 | $19.34 | $155K | 280,573 |
| 2021-05-12 | CHESS ROBERT Director | Option exercise · Stock Option | −8,000 | 24,000 | ||
| 2021-04-14 | CHESS ROBERT Director | Option exercise | +8,000 | $13.80 | $110K | 288,573 |
| 2021-04-14 | CHESS ROBERT Director | Sale | −8,000 | $18.98 | $152K | 280,573 |
| 2021-04-14 | CHESS ROBERT Director | Option exercise · Stock Option | −8,000 | 32,000 | ||
| 2021-02-16 | Zalevsky Jonathan Chief R&D Officer | Sale | −24,141 | $22.37 | $540K | 266,176 |
| 2021-02-16 | Wilson Mark Andrew SVP & General Counsel | Sale | −2,173 | $22.37 | $49K | 76,727 |
| 2021-02-16 | Thomsen Jillian B. SVP & Chief Accounting Officer | Sale | −11,705 | $22.37 | $262K | 164,552 |
| 2021-02-16 | ROBIN HOWARD W President & CEO | Sale | −11,495 | $22.37 | $257K | 447,198 |
| 2021-02-16 | NORTHCOTT JOHN SVP & Chief Commercial Officer | Sale | −15,358 | $22.37 | $344K | 213,192 |
| 2021-02-16 | Labrucherie Gil M SVP, COO & CFO | Sale | −7,977 | $22.37 | $178K | 258,996 |
| 2021-02-04 | ROBIN HOWARD W President & CEO | Option exercise | +150,000 | $8.80 | $1.3M | 608,693 |
| 2021-02-04 | ROBIN HOWARD W President & CEO | Sale | −91,863 | $20.10 | $1.8M | 516,830 |
| 2021-02-04 | ROBIN HOWARD W President & CEO | Sale | −58,137 | $20.58 | $1.2M | 458,693 |
| 2021-02-04 | ROBIN HOWARD W President & CEO | Option exercise · Stock Option | −150,000 | 0 | ||
| 2021-02-04 | Labrucherie Gil M SVP, COO & CFO | Option exercise | +50,000 | $8.80 | $440K | 316,973 |
| 2021-02-04 | Labrucherie Gil M SVP, COO & CFO | Sale | −50,000 | $19.81 | $991K | 266,973 |
| 2021-02-04 | Labrucherie Gil M SVP, COO & CFO | Option exercise · Stock Option | −50,000 | 0 |
Page 14 of 18 · 355 trades